Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Neos Therapeutics, Inc. See All Filings	D/A	2015-02-19 00:00:00 UTC
Amount To Be Raised $20,624,355 Associated Brokers / Dealers N/A CIK Number 0001467652 Filed Document 0001467652-15-000003 Exclusions or Exemptions 506b Accepted Date 2015-02-19 00:00:00 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
Neos Therapeutics, Inc. See All Filings	D	2015-01-06 00:00:00 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers N/A CIK Number 0001467652 Filed Document 0001467652-15-000001 Exclusions or Exemptions 506b Accepted Date 2015-01-06 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
Neos Therapeutics, Inc. See All Filings	D	2014-04-09 00:00:00 UTC
Amount To Be Raised $2,500,000 Associated Brokers / Dealers N/A CIK Number 0001467652 Filed Document 0001467652-14-000003 Exclusions or Exemptions 506b Accepted Date 2014-04-09 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
Neos Therapeutics, Inc. See All Filings	D/A	2014-03-04 00:00:00 UTC
Amount To Be Raised $15,500,170 Associated Brokers / Dealers N/A CIK Number 0001467652 Filed Document 0001467652-14-000002 Exclusions or Exemptions 506b Accepted Date 2014-03-04 00:00:00 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
Neos Therapeutics, Inc. See All Filings	D	2014-01-02 00:00:00 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers N/A CIK Number 0001467652 Filed Document 0001467652-14-000001 Exclusions or Exemptions 506b Accepted Date 2014-01-02 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity